the applicant has developed (outside australia) and sells (outside australia) a stent, known as "the costar stent" which the respondents contend, if it were to be manufactured and sold in australia, would fall within several claims of one or more of the patents in suit.
mr shanley, chief technical officer and a director of the applicant, described in detail the process of research and experimentation leading up to the costar stent prototype.
he said that "[n]either the respondent's patents or the [respondent's stent] could have assisted our development effort.